These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2179201)
1. The antimicrobial activity of fusidic acid. Verbist L J Antimicrob Chemother; 1990 Feb; 25 Suppl B():1-5. PubMed ID: 2179201 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets. Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974 [TBL] [Abstract][Full Text] [Related]
3. Fusidic acid in orthopaedic infections due to coagulase-negative staphylococci. Coombs RR; Menday AP Curr Med Res Opin; 1985; 9(9):587-90. PubMed ID: 3902374 [TBL] [Abstract][Full Text] [Related]
4. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections]. Reynaud AE; Espaze EP; Coste-Burel M; Richet H Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828 [TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States. Jones RN; Mendes RE; Sader HS; Castanheira M Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of methicillin-resistant Staphylococcus aureus and slime-producing and non-slime-producing coagulase-negative staphylococci to fusidic acid. Huebner J; Kropec A; Engels I; Daschner F Chemotherapy; 1992; 38(4):206-10. PubMed ID: 1473358 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada. Pfaller MA; Castanheira M; Sader HS; Jones RN Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520 [TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of adhesion of Staphylococci to biomaterials: effect of fusidic acid]. Drugeon HB; Carpentier E Pathol Biol (Paris); 1993 Apr; 41(4):392-8. PubMed ID: 8233641 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance to fusidic acid in Staphylococcus aureus. Chopra I J Gen Microbiol; 1976 Oct; 96(2):229-38. PubMed ID: 993776 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid? Klein S; Nurjadi D; Eigenbrod T; Bode KA Int J Antimicrob Agents; 2016 Feb; 47(2):155-7. PubMed ID: 26774158 [TBL] [Abstract][Full Text] [Related]
11. Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102). Biedenbach DJ; Rhomberg PR; Mendes RE; Jones RN Diagn Microbiol Infect Dis; 2010 Mar; 66(3):301-7. PubMed ID: 20159376 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis. Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial efficacy of gentamicin-loaded acrylic bone cements with fusidic acid or clindamycin added. Neut D; Hendriks JG; van Horn JR; Kowalski RS; van der Mei HC; Busscher HJ J Orthop Res; 2006 Feb; 24(2):291-9. PubMed ID: 16435362 [TBL] [Abstract][Full Text] [Related]
14. Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections. Fernandes P Cold Spring Harb Perspect Med; 2016 Jan; 6(1):a025437. PubMed ID: 26729758 [TBL] [Abstract][Full Text] [Related]
15. Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococci. Yazdankhah SP; Asli AW; Sørum H; Oppegaard H; Sunde M J Antimicrob Chemother; 2006 Dec; 58(6):1254-6. PubMed ID: 17060340 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data. Rennie RP J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus. Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections. Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F; Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma. Clark SM; Loeffler A; Bond R J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003 [TBL] [Abstract][Full Text] [Related]
20. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci. Roussel-Delvallez M; Wallet F; Barbiery P; Courcol RJ J Chemother; 1997 Feb; 9(1):5-8. PubMed ID: 9106011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]